DE60217300D1 - Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expression - Google Patents
Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expressionInfo
- Publication number
- DE60217300D1 DE60217300D1 DE60217300T DE60217300T DE60217300D1 DE 60217300 D1 DE60217300 D1 DE 60217300D1 DE 60217300 T DE60217300 T DE 60217300T DE 60217300 T DE60217300 T DE 60217300T DE 60217300 D1 DE60217300 D1 DE 60217300D1
- Authority
- DE
- Germany
- Prior art keywords
- integrin expression
- angionegesis
- hemmer
- infringement
- investigating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001044646 | 2001-02-21 | ||
JP2001044646 | 2001-02-21 | ||
PCT/JP2002/001562 WO2002066073A1 (fr) | 2001-02-21 | 2002-02-21 | Procede servant a analyser l'effet d'un inhibiteur d'angiogenese medie par l'inhibition de l'expression de l'integrine |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60217300D1 true DE60217300D1 (de) | 2007-02-15 |
DE60217300T2 DE60217300T2 (de) | 2007-10-04 |
Family
ID=18906601
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60229676T Expired - Lifetime DE60229676D1 (de) | 2001-02-21 | 2002-02-21 | Verfahren zur Untersuchung der Wirkung eines Angiogenese-Hemmers unter Vermittlung durch Hemmung der Integrin-Expression |
DE60217300T Expired - Lifetime DE60217300T2 (de) | 2001-02-21 | 2002-02-21 | Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expression |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60229676T Expired - Lifetime DE60229676D1 (de) | 2001-02-21 | 2002-02-21 | Verfahren zur Untersuchung der Wirkung eines Angiogenese-Hemmers unter Vermittlung durch Hemmung der Integrin-Expression |
Country Status (12)
Country | Link |
---|---|
US (1) | US7122318B2 (de) |
EP (2) | EP1742052B1 (de) |
JP (1) | JP4255285B2 (de) |
KR (1) | KR20030080013A (de) |
CN (2) | CN100384482C (de) |
AT (2) | ATE412895T1 (de) |
AU (1) | AU2002233677B2 (de) |
CA (1) | CA2438427C (de) |
DE (2) | DE60229676D1 (de) |
ES (2) | ES2280502T3 (de) |
HK (2) | HK1059038A1 (de) |
WO (1) | WO2002066073A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2438427C (en) | 2001-02-21 | 2011-04-12 | Eisai Co., Ltd. | Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
US20040235866A1 (en) * | 2001-09-05 | 2004-11-25 | Takahisa Hanada | Lymphocytic activation inhibitor and remedial agent for autoimmune disease |
WO2005090297A1 (en) * | 2004-03-19 | 2005-09-29 | Biotie Therapies Corporation | Sulphonamide derivatives |
WO2006090921A1 (ja) * | 2005-02-28 | 2006-08-31 | Eisai R & D Management Co., Ltd. | スルホンアミド化合物のリンパ球活性化抑制作用 |
RS52010B (en) | 2005-06-22 | 2012-04-30 | Plexxikon Inc. | DERIVATI PIROLO [2, 3-B] PIRIDINA KAO INHIBITORI PROTEIN KINAZE |
FI20055498A0 (fi) * | 2005-09-16 | 2005-09-16 | Biotie Therapies Corp | Sulfonamidijohdannaisia |
WO2007086605A1 (ja) * | 2006-01-27 | 2007-08-02 | Eisai R & D Management Co., Ltd. | スルホンアミド化合物の効果を予測する方法 |
US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
CN112969504B (zh) | 2018-10-30 | 2024-04-09 | 吉利德科学公司 | 用于抑制α4β7整合素的化合物 |
AU2019373242B2 (en) | 2018-10-30 | 2023-07-13 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
AU2019373240B2 (en) | 2018-10-30 | 2023-04-20 | Gilead Sciences, Inc. | Quinoline derivatives as alpha4beta7 integrin inhibitors |
KR102641718B1 (ko) | 2018-10-30 | 2024-02-29 | 길리애드 사이언시즈, 인코포레이티드 | 알파4베타7 인테그린 억제제로서의 이미다조피리딘 유도체 |
WO2021030438A1 (en) | 2019-08-14 | 2021-02-18 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3545461B2 (ja) * | 1993-09-10 | 2004-07-21 | エーザイ株式会社 | 二環式ヘテロ環含有スルホンアミド誘導体 |
RU2128648C1 (ru) * | 1993-09-10 | 1999-04-10 | Эйсай Ко. Лтд. | Производные сульфонамида, способы их получения, фармацевтическая композиция и способ лечения |
ATE203515T1 (de) * | 1996-03-29 | 2001-08-15 | Searle & Co | Meta-substituierte phenylsulphonamidderivate |
AU738782B2 (en) * | 1996-05-31 | 2001-09-27 | Scripps Research Institute, The | Methods and compositions useful for inhibition of alphavbeta5 mediated angiogenesis |
JP2001524079A (ja) * | 1997-04-07 | 2001-11-27 | メルク エンド カンパニー インコーポレーテッド | ガンの治療方法 |
US6096707A (en) * | 1997-07-11 | 2000-08-01 | Biotie Therapies Ltd. | Integrin binding peptide and use thereof |
US6291503B1 (en) | 1999-01-15 | 2001-09-18 | Bayer Aktiengesellschaft | β-phenylalanine derivatives as integrin antagonists |
JP2000247949A (ja) * | 1999-02-26 | 2000-09-12 | Eisai Co Ltd | スルホンアミド含有インドール化合物 |
JP4039856B2 (ja) | 2000-02-03 | 2008-01-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | インテグリン発現阻害剤 |
CA2438427C (en) | 2001-02-21 | 2011-04-12 | Eisai Co., Ltd. | Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
-
2002
- 2002-02-21 CA CA2438427A patent/CA2438427C/en not_active Expired - Fee Related
- 2002-02-21 AT AT06013455T patent/ATE412895T1/de active
- 2002-02-21 JP JP2002565631A patent/JP4255285B2/ja not_active Expired - Fee Related
- 2002-02-21 CN CNB028086376A patent/CN100384482C/zh not_active Expired - Fee Related
- 2002-02-21 DE DE60229676T patent/DE60229676D1/de not_active Expired - Lifetime
- 2002-02-21 EP EP06013455A patent/EP1742052B1/de not_active Expired - Lifetime
- 2002-02-21 AT AT02700679T patent/ATE350660T1/de active
- 2002-02-21 US US10/468,615 patent/US7122318B2/en not_active Expired - Fee Related
- 2002-02-21 CN CNA2007100878177A patent/CN101025419A/zh active Pending
- 2002-02-21 ES ES02700679T patent/ES2280502T3/es not_active Expired - Lifetime
- 2002-02-21 EP EP02700679A patent/EP1362601B8/de not_active Expired - Lifetime
- 2002-02-21 WO PCT/JP2002/001562 patent/WO2002066073A1/ja active IP Right Grant
- 2002-02-21 KR KR10-2003-7010944A patent/KR20030080013A/ko active Search and Examination
- 2002-02-21 DE DE60217300T patent/DE60217300T2/de not_active Expired - Lifetime
- 2002-02-21 ES ES06013455T patent/ES2317368T3/es not_active Expired - Lifetime
- 2002-02-21 AU AU2002233677A patent/AU2002233677B2/en not_active Ceased
-
2004
- 2004-03-16 HK HK04101904A patent/HK1059038A1/xx not_active IP Right Cessation
-
2007
- 2007-06-26 HK HK07106835A patent/HK1099363A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US7122318B2 (en) | 2006-10-17 |
EP1362601A1 (de) | 2003-11-19 |
DE60229676D1 (de) | 2008-12-11 |
WO2002066073A1 (fr) | 2002-08-29 |
HK1059038A1 (en) | 2004-06-18 |
ES2317368T3 (es) | 2009-04-16 |
AU2002233677B2 (en) | 2005-01-06 |
CA2438427C (en) | 2011-04-12 |
DE60217300T2 (de) | 2007-10-04 |
EP1362601A4 (de) | 2005-07-06 |
ES2280502T3 (es) | 2007-09-16 |
ATE412895T1 (de) | 2008-11-15 |
EP1742052B1 (de) | 2008-10-29 |
CN101025419A (zh) | 2007-08-29 |
EP1742052A1 (de) | 2007-01-10 |
EP1362601B1 (de) | 2007-01-03 |
KR20030080013A (ko) | 2003-10-10 |
JPWO2002066073A1 (ja) | 2004-06-17 |
EP1362601B8 (de) | 2007-02-28 |
JP4255285B2 (ja) | 2009-04-15 |
HK1099363A1 (en) | 2007-08-10 |
CA2438427A1 (en) | 2002-08-29 |
CN1620313A (zh) | 2005-05-25 |
US20040132783A1 (en) | 2004-07-08 |
CN100384482C (zh) | 2008-04-30 |
ATE350660T1 (de) | 2007-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60217300D1 (de) | Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expression | |
DE10343896A1 (de) | Testgerät zur Untersuchung von Körperflüssigkeiten | |
ATE404890T1 (de) | Verfahren und vorrichtung zur schnellen tomographischen messung der elektrischen leitfähigkeitsverteilung in einer probe | |
ATE462350T1 (de) | Verfahren und gerät zur laufenden überwachung der konzentration eines analyten | |
WO2005091893A3 (en) | System for high dynamic range analysis in flow cytometry | |
FI20000417A0 (fi) | Ihmiseen liittyvä mittausarviointi | |
Plavcan | Scaling relationships between craniofacial sexual dimorphism and body mass dimorphism in primates: implications for the fossil record | |
DE59608030D1 (de) | Verfahren und vorrichtung zur überprüfung eines sensors | |
DE602004020327D1 (de) | Verfahren zur Detektierung von Temperaturänderungen | |
NO954897L (no) | Fremgangsmåte for å bestemme et individs inflammasjonsindeks fra hele blodfibrinogen og hematokrit eller hemoglobinmålinger | |
CN101512011A (zh) | 在生物介质中测定酶活性的方法 | |
BRPI0409092A (pt) | métodos para medir densidade, para deformar uma imagem de um furo de sondagem, e para efetuar registro de densidade | |
McFarlane et al. | Estimating striae of Retzius periodicity nondestructively using partial counts of perikymata | |
ATE313788T1 (de) | Feuchtigkeitsfühler mit kapazitivem feuchte- messelement und verfahren zur erfassung der luftfeuchtigkeit | |
ATE335434T1 (de) | Vorrichtung und verfahren zur messung der vaskulären impedanz | |
Bechtold et al. | Comparison of field methods and models to estimate mean crown diameter | |
DE60112949D1 (de) | Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes | |
DE602004025676D1 (de) | Verfahren zur untersuchung einer zelle | |
DE602004027399D1 (de) | Verfahren und vorrichtung zum testen eines objekts mit ultraschall | |
DE60203524D1 (de) | Verfahren zur messung des arteriolendrucks | |
DE602008006604D1 (de) | Verfahren zur verarbeitung von spaltkammermesssignalen | |
DE60104327D1 (de) | Verfahren und vorrichtung zur in-line-messung von laserpulsen und verfahren zur messung mittels photoakustischer spektroskopie | |
DE50009357D1 (de) | Verfahren zur bestimmung der belastbarkeit eines menschen | |
ATE363229T1 (de) | Gerät zur herzzeitvolumenbestimmung eines patienten | |
ATE205942T1 (de) | Verfahren und vorrichtung zur messung der strahlungstiefe einer strahlung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |